Previous studies demonstrated that the MYC oncogene appears to play a role in immunogenicity by creating an environment of immune privilege for the tumors themselves, and MYC-targeted therapy induced tumor cell immunogenicity in stimulating host immunity55. The gene discussed is MYC; the disease is neoplasm.